"Solasta was founded based on fundamental research carried out by our team to understand how insects survive and how we could push select insects out without insecticides," Shireen Davies, CEO at Solasta Bio, told Business Insider.
"Current solutions are becoming less effective as insecticide resistance grows, meaning new technologies are gaining interest in the market," Davies added.
"We developed our platform with our tech, which can use selectively targeted peptides, and we've moved fast from the lab to the field, building out our team and technology over the past three years."
"Dutch fund Forbion led the $14 million Series A round alongside FMC Ventures and Corteva Catalyst. This brings Solasta's total raised to date to $19 million."
[
Collection
]
[
|
...
]